Home/Search
2024 Scientific Sessions
Structural Heart Disease
Best of Structural Heart Disease Cases
Transcatheter correction of a "reverse Gerbode defect"
Fabio V. Lima, MD, MPH
Transcatheter Edge-to-Edge Mitral Valve Repair Following Surgical Annuloplasty Ring Dehiscence
Abhushan Poudyal, MD
Percutaneous Closure of a Ruptured Sinus of Valsalva Aneurysm to Right Atrium Fistula
Ivan Hanson, M.D., FSCAI
Percutaneous Closure of Residual Left Atrial Appendage Flow After Failed Surgical Ligation
Rahul Sawhney, DO
TEER The Leaflet
Samantha Michelle Espinosa, MD
Debulking of large mobile mass on bioprosthetic mitral valve using a Novel ŌNŌ
™
Retrieval Device for Embolic Protection in a patient with mycotic stroke
Danish Bawa, MD
Beyond the Leak: Mastering the Use of Plugs and Occluders
Aortic Paravalvular Regurgitation Plugging: A Guide To Effective Techniques
Atman P. Shah, M.D., FSCAI
Visualizing Victory: Fusion Imaging in Mitral Paravalvular Leak
Chad Kliger, M.D., FSCAI
Beyond the Basics: Unexpected Challenges of VSD Closure
John M. Lasala, M.D., Ph.D., MSCAI
Strategies for ASD Closure With an Absent Aortic Rim
Zahid C. Amin, M.D., MSCAI
Off the Beaten Path: Pseudoaneurysm Management
Isida Byku, M.D.
Complications
Iliac Rupture
Jay S. Mathews, MD, FSCAI
TAVR Related Pericardial Effusion
Ranya Sweis, M.D., FSCAI
Management of Coronary Occlusion After TAVR
Homam Ibrahim, M.D., FSCAI
How to Manage TAVR Valve Embolization
James B. Hermiller, M.D., MSCAI
Management of Single Leaflet Device Attachment
Paul Dennis Mahoney, M.D., FSCAI
Unexpected LVOT Obstruction After TMVR
George S. Hanzel, M.D., FSCAI
TMVR Migration/Embolization
Ignacio Inglessis-Azuaje, M.D., FSCAI
Hot Topics in SHD: Debates
TAVR First: The First Intervention for the Young Patient
Steven J. Yakubov, M.D., MSCAI
SAVR First: The First Intervention for the Young Patient
George S. Hanzel, M.D., FSCAI
TEER Will be the Dominant Treatment for TR
Saibal Kar, M.D., FSCAI
TTVR is the Superior Treatment Strategy for TR
Marvin H. Eng, M.D., FSCAI
No Evidence for Cerebral Embolic Protection
Hemal Gada, M.D.
Cerebral Embolic Protection for All
Alexandra J. Lansky, M.D., MSCAI
LAAO
Pre-Procedure Imaging for LAAO Planning
Patrick Gleason, M.D., FSCAI
ICE vs TEE Guidance for LAAO
Megan Coylewright, M.D., FSCAI
Optimal Patient Selection for LAAO
Dr. Andrew Michael Goldsweig, MD, MS, FSCAI
Device Selection for Complex LAA Anatomy
Saibal Kar, M.D., FSCAI
Complications Cases: Device-Related Thrombus
Devi G Nair, MD
Complications Cases: Peri-Device Leak
Himanshu Agarwal, M.D.
Mitral
The Key to Success: Imaging of the Mitral Valve
Patrick Gleason, M.D., FSCAI
M-TEER Cases: The Good, the Bad and the Ugly
Molly Szerlip, M.D., FSCAI
Who Can Get TMVR? Design Criteria and Challenges
Sachin S. Goel, M.D., FSCAI
TMVR Case
Isida Byku, M.D.
Indications and Pre-Procedural Screening for ViV/ViR Procedures
Anita W. Asgar, M.D., FSCAI
ViV/ViR Case Examples
James M. McCabe, MD, FSCAI
Transcatheter MV Interventions: Shaping the Future Landscape for the Next Decade
Christian Spies, M.D.
Structural Heart Disease and Valvular Interventions Featured Abstracts
Midterm Outcomes in an Expanded Cohort of Harmony Transcatheter Pulmonary Valve Recipients
Brian H. Morray, M.D.
No-implant Interatrial Shunt for Heart Failure with Preserved and Mildly-reduced Ejection Fraction: Twelve-month Outcomes from Multi-center ALLEVIATE Feasibility Studies
Binita Shah, M.D., FSCAI
Transcatheter Versus Surgical Mitral Valve Interventions in Patients With Prior Coronary Artery Bypass Grafting
Mahmoud Ismayl, M.D.
Transcatheter Closure of Post-Infarct VSDs with the Amplatzer™ PIVSD Occluder: Results of a U.S. Study
Vijay S. Iyer, M.D., Ph.D., FSCAI
Outcomes of Angiovac for Right Sided Infective Endocarditis
Santul Bapat, MD
Clinical Outcomes of Transcatheter Pulmonary Valve Replacement Versus Surgical Pulmonary Valve Replacement: A Meta-Analysis
Dr. Hasaan Ahmed, MD
Intracardiac Echocardiography Guided Percutaneous Mitral Balloon Commissurotomy Case Series: A New Approach to an old Procedure
Ahmed Hassanin, MD, MPH
Structural Heart Disease: Year in Review
TAVR Year in Review
Chad Kliger, M.D., FSCAI
Tricuspid Year in Review
Mackram F. Eleid, M.D., FSCAI
LAAO Year in Review
Megan Coylewright, M.D., FSCAI
Novel Device Classes Year in Review
Steven J. Yakubov, M.D., MSCAI
Structural Live Cases: Presented by Medical University of South Carolina and Stanford University Medical Center
Stanford University Medical Center (Pre-Recorded)
Rahul Prakash Sharma, M.B.B.S., FSCAI
The TAVR Journey Navigating Lifelong Management and Overcoming Failures
Measure Twice, Cut Once: Anticipating Factors that May Hinder Future ViV/TAV in TAV Therapies
Wayne B. Batchelor, M.D., FSCAI
Future Gazing: Harnessing Simulation for TAVR Optimization
Mohamad Alkhouli, M.D., FSCAI
Mangement Strategies for TAVR Failure: Is It All About Leaflet Modification?
Toby Rogers, MD, PhD
Redo Surgery for TAVR Failure: Indications, Challenges, and Outcomes
Kendra J. Grubb, M.D.
Pacemaker Considerations in Young Patients
Aaron Horne Jr., M.D.
Patient-Prosthesis Mismatch and BVF
Vivian Gar-Yan Ng, M.D., FSCAI
The Future of TAVR: A Glimpse of the New Frontier
Steven J. Yakubov, M.D., MSCAI
Transcatheter Aortic Valve Replacement (TAVR) Featured Abstracts
Neural Networks Yield Good Prediction Models for Patient Pacemaker Implantation Post TAVR
Chris S Abrahim, MD
A Retrospective Analysis Assessing Paravalvular Leak Using a Strategy of TEE and Non-Contrast CT in CKD Patients versus CT Angiography For Annular Sizing Pre-TAVR
Michael O'Shaughnessy, M.D.
META-ANALYSIS COMPARISON OF POST TAVR ANTITHROMBOTIC THERAPY REGIMENS
Ankur Sethi, M.B.B.S., FSCAI
Intermediate Survival of Patients With Pre-Existing or New Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement Treated With Direct Oral Anticoagulants Versus Warfarin
Eduardo Javier Perez, MD
Valve-in-Valve Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Clinical Implications of Permanent Pacemaker Implantation – A Mayo Clinic Study (2012-2022)
Karol Quelal Analuisa, MD
Early Outcomes from the Optimize PRO TAVR Care Pathway Evolut FX System Addendum Study
Hemal Gada, M.D.
High-Sensitivity Cardiac Troponin-T as a Prognostic Indicator of Mortality and Functional Status in Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis
Tyler Andrews, D.O.
National Trends in Transcatheter Aortic Valve Replacement Across Frailty Class
Tanya Sharma, MBBS
Characteristics, Trends, and Outcomes of Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Replacement In the United States: A Nationwide Analysis from the Vizient Clinical Database
Hafiz Muhammad Imran, M.D.
Transcatheter Aortic Valve Replacement (TAVR) Featured Abstracts
Use of Mechanical Circulatory Support for Cardiogenic Shock in Patients Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Analysis from The Vizient Clinical Database
Ali Khan
3-year and 5-year Survival Outcomes in Patients Undergoing VIV-TAVI with and without Bioprosthetic Valve Fracture (BVF)
Marvin Amen
The Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: A Systematic Review and Meta-analysis
Bo Peng, MD., PhD.
Repeat Intervention after Transcatheter Aortic Valve Replacement: Clinical Characteristics and Outcomes of Redo Transcatheter Aortic Valve Replacement and Surgical Explant
Gustavo Mendez Hirata, MD
Transcatheter Aortic Valve Replacement (TAVR) vs Surgical Aortic Valve Replacement (SAVR) in Patients with Liver Cirrhosis- Nationwide Readmission Analysis
Shafaqat Ali, MD
Impact of Endocarditis on Post TAVR Patients: Insight from The National Readmission Database
Sadaf Fakhra
Outcomes of Transcatheter Aortic Valve Replacement In Patients With Amyloidosis: A Comparative Meta-Analysis
Dr. Hasaan Ahmed, MD
Tricuspid
Imaging for Tricuspid Regurgitation: From Anatomy to Patient Selection and Procedural Success
Akhil Narang
Overview of Transcatheter Treatment Options
Ada C Stefanescu Schmidt, M.D., M.Sc., FSCAI
Case 1: Secondary TR (TEER)
Sameer A. Gafoor, M.D., FSCAI
Case 2: Secondary TR (TTVR)
James M. McCabe, MD, FSCAI
Understanding Limitations and Technical Challenges of TTVI
Sachin S. Goel, M.D., FSCAI